VANQUA BIO
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. The company's technology platform utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system.
VANQUA BIO
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.vanquabio.com
Total Employee:
11+
Status:
Active
Contact:
773-360-1673
Email Addresses:
[email protected]
Total Funding:
129.98 M USD
Technology used in webpage:
Digital Ocean Comcast
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
PK Biosciences Corporation
PK Bio is a biotechnology company that produces oral medicines for patients with neurodegenerative diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Logos Capital
Logos Capital investment in Series B - Vanqua Bio
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Vanqua Bio
OrbiMed
OrbiMed investment in Series B - Vanqua Bio
Omega Funds
Omega Funds investment in Series B - Vanqua Bio
Casdin Capital
Casdin Capital investment in Series B - Vanqua Bio
Avoro Ventures
Avoro Ventures investment in Series B - Vanqua Bio
Eli Lilly
Eli Lilly investment in Series B - Vanqua Bio
Pontifax
Pontifax investment in Series B - Vanqua Bio
Surveyor Capital
Surveyor Capital investment in Series B - Vanqua Bio
The Silverstein Foundation
The Silverstein Foundation investment in Grant - Vanqua Bio
Official Site Inspections
http://www.vanquabio.com Semrush global rank: 7.11 M Semrush visits lastest month: 890
- Host name: vanquabio.com-ubuntu20.04
- IP address: 138.68.39.130
- Location: Santa Clara United States
- Latitude: 37.3417
- Longitude: -121.9753
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95051
More informations about "Vanqua Bio"
Home Page - Vanqua Bio
Founded in 2019, is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases. Our novel drug-development approach …See details»
About Us - Vanqua Bio
Vanqua Biois helping usher in a new era of hope for patients living with neurodegenerative disorders. Toward that end, we have assembled a world-class team of scientists, board members, and advisors with proven capabilities in …See details»
Science & Pipeline - Vanqua Bio
Vanqua Bio harnesses leading-edge knowledge of lysosomal biology and the innate immune system, a screening platform using patient iPSC-derived neuronal cells, along with proven drug discovery and development expertise, to …See details»
Vanqua Bio - Crunchbase Company Profile & Funding
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. The company's technology platform utilizes human genetics and patient-derived …See details»
Vanqua Bio - LinkedIn
Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or...See details»
Vanqua Bio: Innovation and New Ventures
Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases. They are helping usher in a new era of hope for the millions of people living with …See details»
Vanqua Bio Launches with $85 Million Series B Financing and a …
CHICAGO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Vanqua Bio, a Chicago-based biopharmaceutical company dedicated to discovering and developing next-generation …See details»
Vanqua Bio Will Use $85M Funding to Advance New Tech Platform
Oct 5, 2021 · Vanqua Bio has raised $85 million in funding to accelerate the development of its small molecule technology platform for treating neurodegenerative disorders such as …See details»
Vanqua Bio Announces Positive Interim Results from Phase 1 …
CHICAGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — Vanqua Bio, a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation …See details»
Vanqua Bio Company Profile 2024: Valuation, Funding …
Operator of a biopharmaceutical company intended to discover and develop next-generation medicines for neurodegenerative diseases.See details»
Vanqua Bio Announces Positive Interim Results from Phase 1
Oct 9, 2024 · Founded in 2019 and headquartered in Chicago, Vanqua Bio is a biopharmaceutical company dedicated to discovering and developing next-generation medicines that have the …See details»
Vanqua Bio Launches with $85 Million Series B Financing and a …
CHICAGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Vanqua Bio, a Chicago-based biopharmaceutical company dedicated to discovering and developing next-generation …See details»
Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, …
Dec 12, 2023 · Vanqua is initially developing VQ-101 for the treatment of Parkinson’s disease with mutations in GBA1 (GBA-PD), the gene that encodes GCase. Mutations in GBA1 are the most …See details»
Vanqua Bio Launches with $85 Million Series B Financing and a …
CHICAGO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Vanqua Bio, a Chicago-based biopharmaceutical company dedicated to discovering and developing next-generation …See details»
Vanqua Bio to Participate in the Leerink Partners Biopharma
Oct 18, 2023 · Founded in 2019 and headquartered in Chicago, Vanqua Bio is a biopharmaceutical company dedicated to discovering and developing next-generation …See details»
Vanqua Bio - Overview, News & Similar companies | ZoomInfo.com
Mar 22, 2023 · View Vanqua Bio (www.vanquabio.com) location in Illinois, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
News & Press - Vanqua Bio
CHICAGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vanqua Bio, a biopharmaceutical company dedicated to discovering and developing next-generation medicines for the treatment of …See details»
Vanqua Bio - VentureRadar
Vanqua Bio harnesses leading-edge knowledge of lysosomal biology and the innate immune system, a screening platform using patient iPSC-derived neuronal cells, along with proven …See details»
Join Our Team - Vanqua Bio
By combining the power of our exemplary science, talented employees, and strategic collaborations, we are strongly positioned to develop new medicines that will transform the …See details»